overview

Novocure® is developing TTFields for different cancer diseases. This website is designed to assist patients, their family members, and caregivers in accessing clinical study sites for potential participation in ongoing studies.

TTFields are electric fields that disrupt cancer cell division. TTFields are delivered to the region of the cancer using a lightweight, battery-operated medical device. The device applies TTFields non-invasively, and gives patients the option to maintain their lifestyle while receiving TTFields treatment.

The use of TTFields has been approved by the FDA via the Premarket Approval Pathway for the treatment of GBM, together with temozolomide. TTFields therapy has obtained a CE mark in Europe, and is approved in Japan for the same indication. TTFields are experimental for all indications mentioned in these clinical studies and has not been approved for their treatment.

clinical trials

METIS

Brain metastasis

LUNAR

Lung cancer

ENGOT-ov50 / INNOVATE-3

Ovarian cancer

TRIDENT

Glioblastoma

ZL-8301-001

Gastric cancer

PANOVA-3

Pancreatic cancer

EF-33

Glioblastoma

KEYNOTE B36

Lung cancer

find a trial

Enter your details below to help us find a trial match for you.

reset